ArticlePloS one2014
Economic effects of introducing alternative Salmonella control strategies in Sweden.
Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Review
- Current evidence of the economic value of One Health initiatives: A systematic literature review.One health (Amsterdam, Netherlands) · 2024Review
- Identification of cost-effective biosecurity measures to reduceFrontiers in veterinary science · 2024Article
- Successful Prevention of Antimicrobial Resistance in Animals-A Retrospective Country Case Study of Sweden.Antibiotics (Basel, Switzerland) · 2021Review
- Zoonotic potential and prevalence ofInfection ecology & epidemiology · 2021Review
- Salmonella Control Programme of Pig Feeds Is Financially Beneficial in Finland.Frontiers in veterinary science · 2019Article
- Cost of Illness for Five Major Foodborne Illnesses and Sequelae in Sweden.Applied health economics and health policy · 2018Article
- Review
- Food safety challenges and One Health within Europe.Acta veterinaria Scandinavica · 2018Review
- Factors affecting costs for on-farm control of salmonella in Swedish dairy herds.Acta veterinaria Scandinavica · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of the study was to analyse the economic effects of introducing alternative Salmonella control strategies in Sweden. Current control strategies in Denmark and the Netherlands were used as benchmarks. The true number of human Salmonella cases was estimated by reconstructing the reporting pyramids for the various scenarios. Costs were calculated for expected changes in human morbidity (Salmonella and two of its sequelae), for differences in the control programmes and for changes in cattle morbidity. The net effects (benefits minus costs) were negative in all scenarios (€ -5 to -105 million), implying that it would not be cost-effective to introduce alternative control strategies in Sweden. This result was mainly due to an expected increase in the incidence of Salmonella in humans (6035-57108 reported and unreported new cases/year), with expected additional costs of € 5-55 million. Other increased costs were due to expected higher incidences of sequelae (€ 3-49 million) and a higher cattle morbidity (€ 4-8 million). Benefits in terms of lower control costs amounted to € 4-7 million.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.